Your session is about to expire
← Back to Search
Vitamin
Vitamin D for Vitamin D Deficiency
Phase 2
Waitlist Available
Led By Mario Chojkier, MD
Research Sponsored by Veterans Medical Research Foundation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up one week
Awards & highlights
All Individual Drugs Already Approved
Summary
Chronic liver diseases are associated with inflammation. The investigators postulate that Vitamin D may modulate inflammation. Thus the investigators will study the effect of Vitamin D replacement in patients with Hepatitis C infection and Vitamin D deficiency.
Eligible Conditions
- Vitamin D Deficiency
- Hepatitis C
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ one week
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~one week
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Macrophage activation
Secondary study objectives
Liver injury
Awards & Highlights
All Individual Drugs Already Approved
Therapies where all constituent drugs have already been approved are likely to have better-understood side effect profiles.
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Vitamin DActive Control1 Intervention
Administration of 500,000 IU Vitamin D orally on Day 1
Group II: PlaceboPlacebo Group1 Intervention
Placebo will be given on Day 1 orally
Find a Location
Who is running the clinical trial?
Veterans Medical Research FoundationLead Sponsor
43 Previous Clinical Trials
4,910 Total Patients Enrolled
Mario Chojkier, MDPrincipal InvestigatorUniversity of California, San Diego
1 Previous Clinical Trials
Share this study with friends
Copy Link
Messenger